Check out your Company Bowl for anonymous work chats.
Greater purpose, making a difference, usher in the future were just some of the reasons three of our colleagues joined GSK. Learn more about GSK Tech and the impact you can help make across the globe. #CareerswithPurpose #GSKTech http://glassdoor.com/slink.htm?key=vQZpt
What Inspired 3 People to Get Into Health Tech
Exciting times at GSK Oncology. Learn more about our recent global strategic alliance and what this could mean for patients living with cancer. #GSKOncology #CareerswithPurpose http://glassdoor.com/slink.htm?key=vQZ4c
GSK on LinkedIn: "Find out how our global strategic alliance with Merck KGaA, Darmstadt, Germany to jointly develop and commercialise a potential first-in-class immunotherapy could potentially bring new answers to patients living with cancer: https://gsk.to/2BmhoII"
Hear from Axel Hoos, Sr. VP of R&D in Oncology at GSK as he describes how GSK plans to help patients with cancer to not only live but live well. Join us if you want to be part of this rewarding vision. Visit our Oncology Career site to learn more. #GSK #oncology #CareerswithPurpose #FacesofGSK http://glassdoor.com/slink.htm?key=vQZFx
Hear from Axel Hoos, Sr. VP of R&D in Oncology at GSK as he describes how GSK plans to help patients with cancer to not only live but live well. Join us if you want to be part of this rewarding vision. Visit our Oncology Career site to learn more. #GSK #oncology #CareerswithPurpose #FacesofGSK http://glassdoor.com/slink.htm?key=vQZFx
Join us in Oncology to help improve the lives of patients around the world. Search ONCOLOGY in our career page of http://glassdoor.com/slink.htm?key=vQoro to find all vacancies. #CareerswithPurpose #FacesofGSK http://glassdoor.com/slink.htm?key=vQorZ
GSK on LinkedIn: "Our oncology scientists, like Kristen and Sarah, are driven by a focus on patients and a deep desire to develop truly transformational medicines that can improve and extend their lives. #WorldCancerDay #IAmandIWill"
For many, failure can be something hard to accept. Carlton, our Head of Global Categories, GSK Consumer Healthcare, shares his thoughts on the importance of taking risk and learning from your mistakes.
For many, failure can be something hard to accept. Carlton, our Head of Global Categories, GSK Consumer Healthcare, shares his thoughts on the importance of taking risk and learning from your mistakes.
We’re honoured that Emmanuel Hanon, our Head of Vaccines R&D, has been inaugurated into the Royal Academy of Belgium. This special recognition is the first time anyone from industry has been granted this opportunity.
We’re honoured that Emmanuel Hanon, our Head of Vaccines R&D, has been inaugurated into the Royal Academy of Belgium. This special recognition is the first time anyone from industry has been granted this opportunity.
Every member of our respiratory team has a role to play in finding the best solutions against respiratory disease. Read more on Elaine’s story here: http://glassdoor.com/slink.htm?key=vQoRN
Following the journey of a respiratory medicine | GSK
What’s the best career advice you’ve been given? Kirk, our Biopharm and Steriles Supply Chain Head, shares some development tips to help you grow in your career. #keepgrowing http://glassdoor.com/slink.htm?key=vQoAT
What’s the best career advice you’ve been given? Kirk, our Biopharm and Steriles Supply Chain Head, shares some development tips to help you grow in your career. #keepgrowing http://glassdoor.com/slink.htm?key=vQoAT
Finding the facts around vaccines amongst all the misinformation can be tough. That’s why we held the ImmunoHack Hackathon. To find new ways of educating patients on the importance of vaccination. Find out how Team Nexus developed their winning idea at http://glassdoor.com/slink.htm?key=vQbOB
GlaxoSmithKline & BeMyApp hackathon + incubation program
Exciting news: GSK completes acquisition of TESARO, an oncology focused biopharmaceutical company. #CareerswithPurpose #CareersinOncology http://glassdoor.com/slink.htm?key=vQbQl
GSK on LinkedIn: "We're very excited to announce today that we have successfully completed the acquisition of TESARO Inc, an oncology-focused company. We welcome nearly 800 TESARO associates onto our team and look forward to accelerating the delivery of transformational medicines to patients with cancer, together. Read more here: https://gsk.to/2FQEYAv"